League Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 21-06-2024
- Paid Up Capital ₹ 0.51 M
as on 21-06-2024
- Company Age 19 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 0.80 M
as on 21-06-2024
- Revenue %
(FY 2016)
- Profit 80.30%
(FY 2016)
- Ebitda 84.85%
(FY 2016)
- Net Worth -1.05%
(FY 2016)
- Total Assets -16.62%
(FY 2016)
About League Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.51 M.
The company has closed loans amounting to ₹0.80 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Parshuram Kongwad, Andreas Reith, Shrivardhan Bhave, and Two other members serve as directors at the Company.
- CIN/LLPIN
U51397PN2005PTC020706
- Company No.
020706
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 May 2005
- Date of AGM
25 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Pune, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at League Pharmaceuticals?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Parshuram Kongwad  | Director | 07-Nov-2005 | Current |
Andreas Reith  | Director | 23-Jan-2008 | Current |
| Shrivardhan Bhave | Director | 23-Jan-2008 | Current |
| Raju Deshmukh | Director | 07-Nov-2005 | Current |
| Harshawardhan Bhawe | Director | 23-Jan-2008 | Current |
Financial Performance of League Pharmaceuticals.
League Pharmaceuticals Private Limited, for the financial year ended 2016, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 80.3% increase in profit. The company's net worth dipped by a decrease of 1.05%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of League Pharmaceuticals?
In 2017, League Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
_PRIVATE_LIMITED.webp)
Prime Oleochem Private LimitedActive 20 years 5 monthsShrivardhan Bhave and Harshawardhan Bhawe are mutual person
- Hightech Energy Feeds (India) Private LimitedActive 24 years 7 days
Shrivardhan Bhave and Harshawardhan Bhawe are mutual person
- Berg And Schmidt (India) Private LimitedActive 22 years 9 months
Shrivardhan Bhave and Harshawardhan Bhawe are mutual person
- Malaysian Vegetable Oils (India) Private LimitedActive 19 years 10 months
Harshawardhan Bhawe is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Corporation Bank Creation Date: 06 Sep 2007 | ₹0.80 M | Satisfied |
How Many Employees Work at League Pharmaceuticals?
Unlock and access historical data on people associated with League Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of League Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped League Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
